 | • レポートコード：GIR-2104Z04215 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、認知症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。認知症治療薬の種類別市場規模（MAO阻害剤、コリンエステラーゼ阻害剤、グルタメート阻害剤）、用途別市場規模（病院薬局、小売薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・認知症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eisai, Inc、Janssen Pharmaceuticals, Inc、Biogen Pharmaceuticals、Forest Laboratories, Inc、Eli Lilly and Company、Novartis AG、Sanofi S.A、AstraZeneca GmbH、F. Hoffmann-La Roche、Merck & Co., Inc、Valeant Pharmaceutical International、Pfizer Inc、Teva Pharmaceuticals Industries ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：MAO阻害剤、コリンエステラーゼ阻害剤、グルタメート阻害剤 ・用途別分析2016年-2026年：病院薬局、小売薬局、その他 ・認知症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・認知症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・認知症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・認知症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・認知症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Dementia Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Dementia Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Dementia Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Dementia Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
MAO Inhibitors
Cholinesterase Inhibitors
Glutamate Inhibitors
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Others
The key market players for global Dementia Drugs market are listed below:
Eisai, Inc
Janssen Pharmaceuticals, Inc
Biogen Pharmaceuticals
Forest Laboratories, Inc
Eli Lilly and Company
Novartis AG
Sanofi S.A
AstraZeneca GmbH
F. Hoffmann-La Roche
Merck & Co., Inc
Valeant Pharmaceutical International
Pfizer Inc
Teva Pharmaceuticals Industries
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Dementia Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dementia Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 MAO Inhibitors
1.2.3 Cholinesterase Inhibitors
1.2.4 Glutamate Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Dementia Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Global Dementia Drugs Market Size & Forecast
1.4.1 Global Dementia Drugs Sales in Value (2016-2026))
1.4.2 Global Dementia Drugs Sales in Volume (2016-2026)
1.4.3 Global Dementia Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Dementia Drugs Production Capacity Analysis
1.5.1 Global Dementia Drugs Total Production Capacity (2016-2026)
1.5.2 Global Dementia Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dementia Drugs Market Drivers
1.6.2 Dementia Drugs Market Restraints
1.6.3 Dementia Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Eisai, Inc
2.1.1 Eisai, Inc Details
2.1.2 Eisai, Inc Major Business
2.1.3 Eisai, Inc Dementia Drugs Product and Services
2.1.4 Eisai, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Janssen Pharmaceuticals, Inc
2.2.1 Janssen Pharmaceuticals, Inc Details
2.2.2 Janssen Pharmaceuticals, Inc Major Business
2.2.3 Janssen Pharmaceuticals, Inc Dementia Drugs Product and Services
2.2.4 Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Biogen Pharmaceuticals
2.3.1 Biogen Pharmaceuticals Details
2.3.2 Biogen Pharmaceuticals Major Business
2.3.3 Biogen Pharmaceuticals Dementia Drugs Product and Services
2.3.4 Biogen Pharmaceuticals Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Forest Laboratories, Inc
2.4.1 Forest Laboratories, Inc Details
2.4.2 Forest Laboratories, Inc Major Business
2.4.3 Forest Laboratories, Inc Dementia Drugs Product and Services
2.4.4 Forest Laboratories, Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Eli Lilly and Company
2.5.1 Eli Lilly and Company Details
2.5.2 Eli Lilly and Company Major Business
2.5.3 Eli Lilly and Company Dementia Drugs Product and Services
2.5.4 Eli Lilly and Company Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business
2.6.3 Novartis AG Dementia Drugs Product and Services
2.6.4 Novartis AG Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sanofi S.A
2.7.1 Sanofi S.A Details
2.7.2 Sanofi S.A Major Business
2.7.3 Sanofi S.A Dementia Drugs Product and Services
2.7.4 Sanofi S.A Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 AstraZeneca GmbH
2.8.1 AstraZeneca GmbH Details
2.8.2 AstraZeneca GmbH Major Business
2.8.3 AstraZeneca GmbH Dementia Drugs Product and Services
2.8.4 AstraZeneca GmbH Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 F. Hoffmann-La Roche
2.9.1 F. Hoffmann-La Roche Details
2.9.2 F. Hoffmann-La Roche Major Business
2.9.3 F. Hoffmann-La Roche Dementia Drugs Product and Services
2.9.4 F. Hoffmann-La Roche Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Merck & Co., Inc
2.10.1 Merck & Co., Inc Details
2.10.2 Merck & Co., Inc Major Business
2.10.3 Merck & Co., Inc Dementia Drugs Product and Services
2.10.4 Merck & Co., Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Valeant Pharmaceutical International
2.11.1 Valeant Pharmaceutical International Details
2.11.2 Valeant Pharmaceutical International Major Business
2.11.3 Valeant Pharmaceutical International Dementia Drugs Product and Services
2.11.4 Valeant Pharmaceutical International Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Pfizer Inc
2.12.1 Pfizer Inc Details
2.12.2 Pfizer Inc Major Business
2.12.3 Pfizer Inc Dementia Drugs Product and Services
2.12.4 Pfizer Inc Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Teva Pharmaceuticals Industries
2.13.1 Teva Pharmaceuticals Industries Details
2.13.2 Teva Pharmaceuticals Industries Major Business
2.13.3 Teva Pharmaceuticals Industries Dementia Drugs Product and Services
2.13.4 Teva Pharmaceuticals Industries Dementia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Dementia Drugs Sales by Manufacturer
3.1 Global Dementia Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Dementia Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Dementia Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Dementia Drugs Manufacturer Market Share
3.4.2 Top 6 Dementia Drugs Manufacturer Market Share
3.5 Global Dementia Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Dementia Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dementia Drugs Market Size by Region
4.1.1 Global Dementia Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Dementia Drugs Revenue by Region (2016-2026)
4.2 North America Dementia Drugs Revenue (2016-2026)
4.3 Europe Dementia Drugs Revenue (2016-2026)
4.4 Asia-Pacific Dementia Drugs Revenue (2016-2026)
4.5 South America Dementia Drugs Revenue (2016-2026)
4.6 Middle East and Africa Dementia Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Dementia Drugs Sales in Volume by Type (2016-2026)
5.2 Global Dementia Drugs Revenue by Type (2016-2026)
5.3 Global Dementia Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Dementia Drugs Sales in Volume by Application (2016-2026)
6.2 Global Dementia Drugs Revenue by Application (2016-2026)
6.3 Global Dementia Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Dementia Drugs Sales by Type (2016-2026)
7.2 North America Dementia Drugs Sales by Application (2016-2026)
7.3 North America Dementia Drugs Market Size by Country
7.3.1 North America Dementia Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Dementia Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Dementia Drugs Sales by Type (2016-2026)
8.2 Europe Dementia Drugs Sales by Application (2016-2026)
8.3 Europe Dementia Drugs Market Size by Country
8.3.1 Europe Dementia Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Dementia Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Dementia Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Dementia Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Dementia Drugs Market Size by Region
9.3.1 Asia-Pacific Dementia Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Dementia Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Dementia Drugs Sales by Type (2016-2026)
10.2 South America Dementia Drugs Sales by Application (2016-2026)
10.3 South America Dementia Drugs Market Size by Country
10.3.1 South America Dementia Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Dementia Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dementia Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Dementia Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Dementia Drugs Market Size by Country
11.3.1 Middle East & Africa Dementia Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Dementia Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Dementia Drugs Typical Distributors
12.3 Dementia Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Dementia Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Dementia Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Eisai, Inc Basic Information, Manufacturing Base and Competitors
Table 4. Eisai, Inc Major Business
Table 5. Eisai, Inc Dementia Drugs Product and Services
Table 6. Eisai, Inc Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Janssen Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 8. Janssen Pharmaceuticals, Inc Major Business
Table 9. Janssen Pharmaceuticals, Inc Dementia Drugs Product and Services
Table 10. Janssen Pharmaceuticals, Inc Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biogen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Biogen Pharmaceuticals Major Business
Table 13. Biogen Pharmaceuticals Dementia Drugs Product and Services
Table 14. Biogen Pharmaceuticals Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Forest Laboratories, Inc Basic Information, Manufacturing Base and Competitors
Table 16. Forest Laboratories, Inc Major Business
Table 17. Forest Laboratories, Inc Dementia Drugs Product and Services
Table 18. Forest Laboratories, Inc Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly and Company Major Business
Table 21. Eli Lilly and Company Dementia Drugs Product and Services
Table 22. Eli Lilly and Company Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 24. Novartis AG Major Business
Table 25. Novartis AG Dementia Drugs Product and Services
Table 26. Novartis AG Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sanofi S.A Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi S.A Major Business
Table 29. Sanofi S.A Dementia Drugs Product and Services
Table 30. Sanofi S.A Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. AstraZeneca GmbH Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca GmbH Major Business
Table 33. AstraZeneca GmbH Dementia Drugs Product and Services
Table 34. AstraZeneca GmbH Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 36. F. Hoffmann-La Roche Major Business
Table 37. F. Hoffmann-La Roche Dementia Drugs Product and Services
Table 38. F. Hoffmann-La Roche Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 40. Merck & Co., Inc Major Business
Table 41. Merck & Co., Inc Dementia Drugs Product and Services
Table 42. Merck & Co., Inc Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Valeant Pharmaceutical International Basic Information, Manufacturing Base and Competitors
Table 44. Valeant Pharmaceutical International Major Business
Table 45. Valeant Pharmaceutical International Dementia Drugs Product and Services
Table 46. Valeant Pharmaceutical International Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 48. Pfizer Inc Major Business
Table 49. Pfizer Inc Dementia Drugs Product and Services
Table 50. Pfizer Inc Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Teva Pharmaceuticals Industries Basic Information, Manufacturing Base and Competitors
Table 52. Teva Pharmaceuticals Industries Major Business
Table 53. Teva Pharmaceuticals Industries Dementia Drugs Product and Services
Table 54. Teva Pharmaceuticals Industries Dementia Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Dementia Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Dementia Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Dementia Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Dementia Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Dementia Drugs Production Site of Key Manufacturer
Table 60. Global Dementia Drugs Sales by Region (2016-2021e) & (K Units)
Table 61. Global Dementia Drugs Sales by Region (2021-2026) & (K Units)
Table 62. Global Dementia Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Dementia Drugs Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Dementia Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. Global Dementia Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Global Dementia Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Dementia Drugs Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Dementia Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 69. Global Dementia Drugs Price by Type (2021-2026) & (USD/Unit)
Table 70. Global Dementia Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. Global Dementia Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Global Dementia Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Dementia Drugs Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Dementia Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 75. Global Dementia Drugs Price by Application (2021-2026) & (USD/Unit)
Table 76. North America Dementia Drugs Sales by Country (2016-2021e) & (K Units)
Table 77. North America Dementia Drugs Sales by Country (2021-2026) & (K Units)
Table 78. North America Dementia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Dementia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Dementia Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. North America Dementia Drugs Sales by Type (2021-2026) & (K Units)
Table 82. North America Dementia Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. North America Dementia Drugs Sales by Application (2021-2026) & (K Units)
Table 84. Europe Dementia Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. Europe Dementia Drugs Sales by Country (2021-2026) & (K Units)
Table 86. Europe Dementia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Dementia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Dementia Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. Europe Dementia Drugs Sales by Type (2021-2026) & (K Units)
Table 90. Europe Dementia Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. Europe Dementia Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Asia-Pacific Dementia Drugs Sales by Region (2016-2021e) & (K Units)
Table 93. Asia-Pacific Dementia Drugs Sales by Region (2021-2026) & (K Units)
Table 94. Asia-Pacific Dementia Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Dementia Drugs Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Dementia Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. Asia-Pacific Dementia Drugs Sales by Type (2021-2026) & (K Units)
Table 98. Asia-Pacific Dementia Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. Asia-Pacific Dementia Drugs Sales by Application (2021-2026) & (K Units)
Table 100. South America Dementia Drugs Sales by Country (2016-2021e) & (K Units)
Table 101. South America Dementia Drugs Sales by Country (2021-2026) & (K Units)
Table 102. South America Dementia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Dementia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Dementia Drugs Sales by Type (2016-2021e) & (K Units)
Table 105. South America Dementia Drugs Sales by Type (2021-2026) & (K Units)
Table 106. South America Dementia Drugs Sales by Application (2016-2021e) & (K Units)
Table 107. South America Dementia Drugs Sales by Application (2021-2026) & (K Units)
Table 108. Middle East & Africa Dementia Drugs Sales by Country (2016-2021e) & (K Units)
Table 109. Middle East & Africa Dementia Drugs Sales by Country (2021-2026) & (K Units)
Table 110. Middle East & Africa Dementia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Dementia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Dementia Drugs Sales by Type (2016-2021e) & (K Units)
Table 113. Middle East & Africa Dementia Drugs Sales by Type (2021-2026) & (K Units)
Table 114. Middle East & Africa Dementia Drugs Sales by Application (2016-2021e) & (K Units)
Table 115. Middle East & Africa Dementia Drugs Sales by Application (2021-2026) & (K Units)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Dementia Drugs Typical Distributors
Table 119. Dementia Drugs Typical Customers
List of Figures
Figure 1. Dementia Drugs Picture
Figure 2. Global Dementia Drugs Sales Market Share by Type in 2020
Figure 3. MAO Inhibitors
Figure 4. Cholinesterase Inhibitors
Figure 5. Glutamate Inhibitors
Figure 6. Global Dementia Drugs Sales Market Share by Application in 2020
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Others
Figure 10. Global Dementia Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Dementia Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Dementia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Dementia Drugs Sales (2016-2026) & (K Units)
Figure 32. Global Dementia Drugs Production Capacity (2016-2026) & (K Units)
Figure 33. Global Dementia Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Dementia Drugs Market Drivers
Figure 35. Dementia Drugs Market Restraints
Figure 36. Dementia Drugs Market Trends
Figure 37. Global Dementia Drugs Sales Market Share by Manufacturer in 2020
Figure 38. Global Dementia Drugs Revenue Market Share by Manufacturer in 2020
Figure 39. Dementia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Dementia Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Dementia Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Dementia Drugs Sales Market Share by Region (2016-2026)
Figure 43. Global Dementia Drugs Revenue Market Share by Region (2016-2026)
Figure 44. North America Dementia Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Europe Dementia Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Dementia Drugs Revenue (2016-2026) & (USD Million)
Figure 47. South America Dementia Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Dementia Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Global Dementia Drugs Sales Market Share by Type (2016-2026)
Figure 50. Global Dementia Drugs Revenue Market Share by Type (2016-2026)
Figure 51. Global Dementia Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Dementia Drugs Sales Market Share by Application (2016-2026)
Figure 53. Global Dementia Drugs Revenue Market Share by Application (2016-2026)
Figure 54. Global Dementia Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Dementia Drugs Sales Market Share by Country (2016-2026)
Figure 56. North America Dementia Drugs Revenue Market Share by Country (2016-2026)
Figure 57. North America Dementia Drugs Sales Market Share by Type (2016-2026)
Figure 58. North America Dementia Drugs Sales Market Share by Application (2016-2026)
Figure 59. Europe Dementia Drugs Sales Market Share by Country (2016-2026)
Figure 60. Europe Dementia Drugs Revenue Market Share by Country (2016-2026)
Figure 61. Europe Dementia Drugs Sales Market Share by Type (2016-2026)
Figure 62. Europe Dementia Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Dementia Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Dementia Drugs Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Dementia Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Dementia Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Dementia Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Dementia Drugs Revenue Market Share by Country (2016-2026)
Figure 69. South America Dementia Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Dementia Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Dementia Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Dementia Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Dementia Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Dementia Drugs Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の認知症・運動障害治療市場規模・現状・予測（2021年-2027年） Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality change…- 世界の多発梗塞性認知症市場規模・現状・予測（2021年-2027年） Multi-cerebral infarction dementia is a series of small strokes that cause disruption of blood flow to the brain. It is the highest incidence among people over 65 years of age. The increase in the global elderly population has also contributed to the development of the global market for multi-infarc…
- 世界のバーター症候群治療薬市場規模・現状・予測（2021年-2027年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% du…
- 世界の植物・植物由来薬剤市場規模・現状・予測（2021年-2027年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…
- 世界のマイクロバイオーム医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Microbiome Drugs Market The global Microbiome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a b…